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Fulminant type 1 diabetes has been defined as a new
subtype of type 1 diabetes in which pancreatic islet cell
failure rapidly leads to hyperglycemia and ketoacido-
sis, with an average onset of 4 days. It is characterized
by normal or near normal glycosylated hemoglobin
levels, an absence of autoantibodies against islet cells,
glutamic acid decarboxylase, insulinoma-associated
protein 2/islet cell antigen 512 and insulin, as well as
the involvement of the exocrine pancreas, with ele-
vated serum levels of pancreatic enzymes [1–3]. This
disease sometimes occurs during the third trimester of
pregnancy or just after delivery [4], with an extremely
poor prognosis for the fetus.
CASE PRESENTATION
A previously healthy 28-year-old Chinese woman pre-
sented at her local obstetrics and gynecology hospital
in week 33 of gestation with generalized abdominal
cramping and massive vaginal bleeding. A vaginal
examination demonstrated that her cervix was fully
dilated and a stillbirth was delivered approximately 12
minutes after she arrived at the hospital. The patient also
complained of polyuria, polydipsia, nausea, vomiting,
poor appetite, constipation and shortness of breath for
1 week before the admission, without other signs of
infection. She was gravida 2 para 1, and her past
medical and obstetrical histories were unremarkable.
Her past obstetrical history included one prior preg-
nancy with the delivery of a healthy boy by normal
spontaneous delivery. During that pregnancy, routine
screening for gestational diabetes was negative.
During week 30 of pregnancy, the patient under-
went a 50-g oral glucose tolerance test, which was
mildly elevated (Table 1). A follow up 100-g oral glu-
cose tolerance test was performed during week 31, 11
days before the present admission, and was normal
(Table 1). The patient’s medical records showed that
urinalysis and fetal heart monitoring had been per-
formed on multiple occasions before admission, in-
cluding the day before presentation, but ketonuria and
glucosuria were not found and the fetal heart rate was
consistently within the normal limits.
Upon arrival at our center, physical examination
revealed that the patient was alert and orientated, but
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weak and distressed. Her vital signs were as follows:
blood pressure 116/80 mmHg, pulse 142 beats/min,
respiratory rate 28 breaths/min and body temperature
37.7°C. Her abdomen was not tender, and there were
no localized signs of infection. Initial laboratory in-
vestigations demonstrated severe glucosuria and
ketonuria, and severe metabolic acidosis (pH 7.09) with
an elevated anion gap of 22 mmol/L. Hyperglycemia
with leukocytosis, and a low serum sodium level,
were also noticed (Table 2). Based on these findings,
diabetic ketoacidosis was suspected. Further investi-
gations for newly diagnosed diabetes mellitus, includ-
ing autoimmune status, were performed, but yielded
no significant results (Table 3). In the immediate post-
partum period, aggressive management of diabetic
ketoacidosis was conducted according to local guide-
lines. The patient regained good glycemic control and
was discharged and treated with insulin and an oral
hypoglycemic agent.
DISCUSSION
In rare instances, diabetes mellitus may first manifest
as diabetic ketoacidosis during pregnancy. In this case
report, the patient was negative for gestational diabetes
only 11 days before presenting with ketoacidosis. Her
medical records showed that the glucose load was
administered correctly and there was no mention of
any emesis during the test period.
The initial mildly elevated glycosylated hemoglo-
bin level showed that the patient did not have any sig-
nificant disturbances in glucose metabolism during the
months prior to this episode. Thus, this may represent
Table 1. Prenatal screening report for gestational 
diabetes
Value Normal range
(mmol/L) (mmol/L)
Gestational week 30/40: 
50-g OGTT
1 hr 8.11 < 7.77
Gestational week 31/40: 
100-g OGTT
Fasting glucose 4.33 < 5.27
1 hr 9.05 < 10.00
2 hr 7.00 < 8.61
3 hr 6.22 < 7.77
OGTT = oral glucose tolerance test.
Table 2. Laboratory data upon presentation to the
emergency room
Value Normal range
Arterial blood gas 
analysis on air
pH 7.1 7.4–7.5
pCO2 (kPa) 1.8 4.3–6.0
pO2 (kPa) 14.8 9.6–13.8
HCO3 (mmol/L) 4.1 22.0–30.0
Blood/plasma chemistry
Serum fasting 34.2 4.2–6.1
glucose (mmol/L)
Sodium (mmol/L) 124.0 136.0–146.0
Potassium (mmol/L) 5.4 3.5–5.0
Chloride (mmol/L) 98.0 102.0–109.0
Lactate (mmol/L) 1.7 0.5–2.2
Amylase (ukat/L) 7.1 0.3–1.6
WBC count (/μl) 39,390 4,000–10,000
Neutrophils 0.80 0.40–0.70
Eosinophils 0.003 0.00–0.60
Basophils 0.002 0.00–0.02
Lymphocytes 0.25 0.20–0.50
Monocytes 0.05 0.04–0.08
Hematocrit 0.44 0.35–0.44
Urinalysis
Glucose 3+
Ketones 4+
WBC = white blood cell.
Table 3. Laboratory data after new diagnosis of dia-
betes mellitus
Value Normal range
HbA1c (Hb fraction) 0.07 0.04–0.06
Anti-GADAb Neg
ANA Neg
TGB and microsomal Ab Neg
IgG (g/L) 8.78 7.00–17.00
IgA (g/L) 1.80 0.70–3.50
IgM (g/L) 1.13 0.50–3.00
C3 (g/L) 1.21 0.83–1.77
C4 (mg/dL) 0.24 0.16–0.47
T3 (nmol/L) 1.68 1.20–2.10
FT4 (pmol/L) 12.70 10.30–21.90
TSH (mIU/L) 2.00 0.34–4.25
TSHRAb Neg
C-peptide (nmol/L) < 0.10 0.17–0.66
HbA1c=glycosylated hemoglobin; Anti-GADAb=anti-glutamic
acid decarboxylase antibody; ANA = antinuclear antibody;
TGB = thyroglobulin; Ig = immunoglobulin; C = complement;
T3 = total triiodothyronine; FT4 = free thyroxine; TSH = thyroid
stimulating hormone; TSHRAb = thyroid stimulating hormone
receptor antibody; Neg = negative.
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a case of fulminant type 1 diabetes, as described by
Toshiaki Hanafusa in his review on this rare disease,
with the key characteristics of near normal glycosy-
lated hemoglobin and very high plasma glucose levels
with severe ketoacidosis [5]. The plasma C-peptide
level is also markedly decreased. It is probable that a
rapid depletion in insulin, coupled with the stress of
labor, precipitated diabetic ketoacidosis in this patient
with disastrous consequences for the fetus.
The symptoms and signs of fulminant type 1 dia-
betes with ketoacidosis in pregnancy are similar to
those in non-diabetics; however, it has been demon-
strated that, during pregnancy, diabetic ketoacidosis
can occur at glucose levels as low as 200 mg/dL (nor-
mal > 250 mg/dL) [6]. Remarkable symptoms, such as
common cold like symptoms and abdominal symp-
toms, particularly nausea and vomiting with abdom-
inal pain, were pertinent in this case.
The patient did not have a clear history of ante-
cedent viral infection or toxin exposure prior to this
event, but a sub-clinical or minimally symptomatic
infection could have been present. However, an asso-
ciation between acute islet cell failure and recent viral
infection in humans remains purely theoretical. Nev-
ertheless, the onset of fulminant type 1 diabetes is often
associated with herpes viruses, enteroviruses such as
coxsackie viruses, and echoviruses [7–11].
Although viruses may be the pathogenic agents, 
a few studies have strongly suggested that certain
class II HLA DR4-DQ4 genotypes encoded by DRB1
0405-DQB1 0401 can increase the susceptibility to this
disease [12–15].
Immune reactions might also play a role [12–15]. 
T lymphocytes might respond to glutamic acid decar-
boxylase, although this does not mean that autoimmu-
nity plays the primary role [16,17]. In the present case,
titers for islet cell antibodies were obtained at the
time of presentation and were negative. Although this
information is not critical to the management of a
patient, such tests can enhance our understanding 
of such cases.
In summary, fulminant type 1 diabetes is a newly
discovered subtype of type 1 diabetes that needs spe-
cial attention because of its rapid rate of onset in appar-
ently healthy subjects, particularly during pregnancy.
Diabetic ketoacidosis can be successfully managed
during pregnancy if basic principles are followed. The
precipitating factors such as accelerated starvation,
pregnancy-associated nausea and vomiting, infection,
non compliance insulin pump failure, tocolytic agents
like beta sympathomimetic drugs and corticosteroids
should be identified and corrected, as appropriate.
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中國籍懷孕婦女併發猛爆性第 1 型糖尿病
導致流產之病例
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本病例報告一位懷孕 33 週婦女，接受口服葡萄糖耐受測試，結果為正常，卻在短短 
11 天後引起糖尿病酮酸血症，導致子宮內胎兒死亡。此可為一件猛爆性第 1 型糖尿病
的病例。
關鍵詞：糖尿病酮酸血症，猛爆性第 1 型糖尿病，子宮內胎兒死亡
（高雄醫誌 2010;26:310–20）
